CIA
INSM icon

Capital Investment Advisors’s Insmed INSM Stock Holding History

Capital Investment Advisors’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.41M Sell
13,238
-7
-0.1% -$848 0.02% 308
2026
Q1 		$2.17M Buy
+13,245
New +$2.04M 0.03% 227

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Capital Investment Advisors's INSM Position: Q2 2026 in Review

Capital Investment Advisors reduced its Insmed (INSM) stake by 0.05% in Q2 2026, selling an estimated $848 and leaving 13,238 shares worth $1.41M. The position accounts for 0.02% of the portfolio, ranked #308.

Capital Investment Advisors first reported a position in INSM in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.17M in Q1 2026. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Capital Investment Advisors held 13,238 shares of Insmed worth $1.41M as of Q2 2026.
  • Capital Investment Advisors sold 7 Insmed shares in Q2 2026, an estimated $848.
  • Insmed made up 0.02% of Capital Investment Advisors's portfolio in Q2 2026, its #308 holding.
  • Capital Investment Advisors first reported a position in Insmed in Q1 2026 and has held it in 2 quarters since.
  • Capital Investment Advisors's Insmed position peaked at $2.17M in Q1 2026.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Capital Investment Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.